{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:26:04Z","timestamp":1773901564536,"version":"3.50.1"},"reference-count":121,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009794","name":"Breast Cancer Now","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Lobular carcinoma represent the most common special histological subtype of breast cancer, with the majority classed as hormone receptor positive. Rates of invasive lobular carcinoma in postmenopausal women have been seen to increase globally, while other hormone receptor\u2013positive breast cancers proportionally have not followed the same trend. This has been linked to exposure to exogenous ovarian hormones such as hormone replacement therapy. Reproductive factors resulting in increased lifetime exposure to endogenous ovarian hormones have also been linked to an increased risk of lobular breast cancer, and taken together, these data make a case for the role of ovarian hormones in the genesis and progression of the disease. In this review, we summarize current understanding of the epidemiological associations between ovarian hormones and lobular breast cancer and highlight mechanistic links that may underpin the etiology and biology.<\/jats:p>","DOI":"10.1210\/endocr\/bqae031","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T23:49:54Z","timestamp":1711583394000},"source":"Crossref","is-referenced-by-count":2,"title":["Is There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?"],"prefix":"10.1210","volume":"165","author":[{"given":"Ren\u00e9e L","family":"Flaherty","sequence":"first","affiliation":[{"name":"Division of Breast Cancer Research, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research , London SW3 6JB , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Sflomos","sequence":"additional","affiliation":[{"name":"Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne (EPFL) , CH-1015 Lausanne , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6857-3230","authenticated-orcid":false,"given":"Cathrin","family":"Brisken","sequence":"additional","affiliation":[{"name":"Division of Breast Cancer Research, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research , London SW3 6JB , UK"},{"name":"Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne (EPFL) , CH-1015 Lausanne , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"issue":"6797","key":"2024042901110140900_bqae031-B1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"2024042901110140900_bqae031-B2","volume-title":"Pathology and Genetics of Tumours of the Breast and Female Genital Organs","author":"Tavassoli","year":"2003"},{"issue":"2","key":"2024042901110140900_bqae031-B3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/path.2407","article-title":"Refinement of breast cancer classification by molecular characterization of histological special types","volume":"216","author":"Weigelt","year":"2008","journal-title":"J Pathol"},{"issue":"1","key":"2024042901110140900_bqae031-B4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.epirev.a036102","article-title":"Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk","volume":"15","author":"Pike","year":"1993","journal-title":"Epidemiol Rev"},{"issue":"3","key":"2024042901110140900_bqae031-B5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12672-016-0259-0","article-title":"The metabolism, analysis, and targeting of steroid hormones in breast and prostate cancer","volume":"7","author":"Capper","year":"2016","journal-title":"Horm Cancer"},{"issue":"9017","key":"2024042901110140900_bqae031-B6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast, C","year":"1996","journal-title":"Lancet (London, England)"},{"issue":"9392","key":"2024042901110140900_bqae031-B7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"issue":"10204","key":"2024042901110140900_bqae031-B8","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","author":"Cancer","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"2024042901110140900_bqae031-B9","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S1470-2045(06)70911-1","article-title":"Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis","volume":"7","author":"Reeves","year":"2006","journal-title":"Lancet Oncol"},{"issue":"2","key":"2024042901110140900_bqae031-B10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000350774","article-title":"A brief overview of the WHO classification of breast tumors, 4th edition, focusing on issues and updates from the 3rd edition","volume":"8","author":"Sinn","year":"2013","journal-title":"Breast care"},{"issue":"1","key":"2024042901110140900_bqae031-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40487-019-00105-0","article-title":"Invasive lobular breast cancer as a distinct disease: implications for therapeutic strategy","volume":"8","author":"Luveta","year":"2020","journal-title":"Oncol Ther"},{"issue":"7","key":"2024042901110140900_bqae031-B12","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s41379-021-00742-9","article-title":"Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations","volume":"34","author":"Bergeron","year":"2021","journal-title":"Mod Pathol"},{"key":"2024042901110140900_bqae031-B13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.breast.2021.06.011","article-title":"Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations","volume":"59","author":"Conforti","year":"2021","journal-title":"Breast"},{"issue":"1","key":"2024042901110140900_bqae031-B14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13058-015-0519-x","article-title":"Invasive lobular carcinoma of the breast: morphology, biomarkers and \u2018omics","volume":"17","author":"McCart Reed","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"2","key":"2024042901110140900_bqae031-B15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10549-011-1860-0","article-title":"Cadherin-catenin complex dissociation in lobular neoplasia of the breast","volume":"132","author":"Morrogh","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2024042901110140900_bqae031-B16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/B:BREA.0000021038.97593.8b","article-title":"A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast","volume":"85","author":"Korhonen","year":"2004","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2024042901110140900_bqae031-B17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"issue":"8","key":"2024042901110140900_bqae031-B18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.annonc.2022.05.006","article-title":"Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer","volume":"33","author":"Van Baelen","year":"2022","journal-title":"Ann Oncol"},{"key":"2024042901110140900_bqae031-B19","doi-asserted-by":"crossref","first-page":"2021-6-6","DOI":"10.7573\/dic.2021-6-6","article-title":"Leptomeningeal carcinomatosis and breast cancer: a systematic review of current evidence on diagnosis, treatment and prognosis","volume":"10","author":"Mollica","year":"2021","journal-title":"Drugs Context"},{"issue":"06","key":"2024042901110140900_bqae031-B20","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1055\/s-0043-109374","article-title":"Distinct pattern of metastases in patients with invasive lobular carcinoma of the breast","volume":"77","author":"Mathew","year":"2017","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"1","key":"2024042901110140900_bqae031-B21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejca.2007.10.009","article-title":"Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes","volume":"44","author":"Rakha","year":"2008","journal-title":"Eur J Cancer"},{"issue":"25","key":"2024042901110140900_bqae031-B22","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1200\/JCO.2015.60.8133","article-title":"Relative effectiveness of letrozole compared with tamoxifen for patients with lobular carcinoma in the BIG 1\u201398 trial","volume":"33","author":"Metzger Filho","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"2024042901110140900_bqae031-B23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12885-016-2275-4","article-title":"Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma","volume":"16","author":"Adachi","year":"2016","journal-title":"BMC Cancer"},{"issue":"18","key":"2024042901110140900_bqae031-B24","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1200\/JCO.2007.14.9336","article-title":"Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials","volume":"26","author":"Pestalozzi","year":"2008","journal-title":"J Clin Oncol"},{"issue":"6","key":"2024042901110140900_bqae031-B25","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.11032","article-title":"Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland","volume":"104","author":"Verkooijen","year":"2003","journal-title":"Int J Cancer"},{"issue":"3","key":"2024042901110140900_bqae031-B26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-007-9554-3","article-title":"Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations","volume":"107","author":"Verkooijen","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"2024042901110140900_bqae031-B27","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1002\/1097-0142(20000601)88:11<2561::AID-CNCR19>3.0.CO;2-X","article-title":"Changing incidence rate of invasive lobular breast carcinoma among older women","volume":"88","author":"Li","year":"2000","journal-title":"Cancer"},{"issue":"4","key":"2024042901110140900_bqae031-B28","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-04-0849","article-title":"Age-Specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001","volume":"14","author":"Li","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"2024042901110140900_bqae031-B29","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1158\/1055-9965.EPI-08-1082","article-title":"The changing incidence of in situ and invasive ductal and lobular breast carcinomas: united States, 1999\u20132004","volume":"18","author":"Eheman","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2024042901110140900_bqae031-B30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal WomenPrincipal results from the Women's health initiative randomized controlled trial","volume":"288","author":"Writing Group for the Women's Health Initiative, I.","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"2024042901110140900_bqae031-B31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pds.985","article-title":"Use of menopausal hormones in the United States, 1992 through June, 2003","volume":"14","author":"Wysowski","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"2024042901110140900_bqae031-B32","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1470-2045(12)70425-4","article-title":"Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies","volume":"13","author":"Collaborative Group on Hormonal Factors in Breast, C.","year":"2012","journal-title":"Lancet Oncology"},{"issue":"5","key":"2024042901110140900_bqae031-B33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/bcr628","article-title":"Oestrogen exposure and breast cancer risk","volume":"5","author":"Travis","year":"2003","journal-title":"Breast Cancer Res"},{"issue":"3","key":"2024042901110140900_bqae031-B34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1470-2045(00)00254-0","article-title":"Epidemiology of breast cancer","volume":"2","author":"Key","year":"2001","journal-title":"Lancet Oncol"},{"issue":"5","key":"2024042901110140900_bqae031-B35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jnci\/50.5.1111","article-title":"On the origin and progression of ductal carcinoma in the human breast2","volume":"50","author":"Wellings","year":"1973","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"12","key":"2024042901110140900_bqae031-B36","doi-asserted-by":"crossref","first-page":"a003178","DOI":"10.1101\/cshperspect.a003178","article-title":"Hormone action in the mammary gland","volume":"2","author":"Brisken","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"2024042901110140900_bqae031-B37","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ijc.2910460408","article-title":"Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries","volume":"46","author":"Ewertz","year":"1990","journal-title":"Int J Cancer"},{"issue":"2","key":"2024042901110140900_bqae031-B38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cjp2.253","article-title":"Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma","volume":"8","author":"Christgen","year":"2022","journal-title":"J Pathol Clin Res"},{"issue":"3","key":"2024042901110140900_bqae031-B39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.bjc.6604853","article-title":"Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis","volume":"100","author":"Reeves","year":"2009","journal-title":"Br J Cancer"},{"issue":"2","key":"2024042901110140900_bqae031-B40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/aje\/kwm271","article-title":"Timing of menarche and first full-term birth in relation to breast cancer risk","volume":"167","author":"Li","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"6","key":"2024042901110140900_bqae031-B41","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/bcr2790","article-title":"Risk factors for ductal and lobular breast cancer: results from the nurses\u2019 health study","volume":"12","author":"Kotsopoulos","year":"2010","journal-title":"Breast Cancer Res"},{"issue":"9","key":"2024042901110140900_bqae031-B42","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/cncr.25728","article-title":"Late age at first full term birth is strongly associated with lobular breast cancer","volume":"117","author":"Newcomb","year":"2011","journal-title":"Cancer"},{"issue":"10","key":"2024042901110140900_bqae031-B43","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1158\/1055-9965.EPI-07-0242","article-title":"Relationship between age maximum height is attained, age at menarche, and age at first full-term birth and breast cancer risk","volume":"16","author":"Li","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"2024042901110140900_bqae031-B44","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/ijc.24494","article-title":"Parity and age at first childbirth in relation to the risk of different breast cancer subgroups","volume":"125","author":"Butt","year":"2009","journal-title":"Int J Cancer"},{"issue":"3","key":"2024042901110140900_bqae031-B45","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/sj.bjc.6602712","article-title":"Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology","volume":"93","author":"Ursin","year":"2005","journal-title":"Br J Cancer"},{"issue":"3","key":"2024042901110140900_bqae031-B46","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/bcr767","article-title":"Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome","volume":"6","author":"Arpino","year":"2004","journal-title":"Breast Cancer Res"},{"key":"2024042901110140900_bqae031-B47","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0959-8049(20)30542-6","article-title":"6 oral\u2014clinical utility of MammaPrint testing in invasive lobular carcinoma: results from the MINDACT phase III trial","volume":"138","author":"Metzger","year":"2020","journal-title":"Eur J Cancer"},{"issue":"1","key":"2024042901110140900_bqae031-B48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10552-017-0977-9","article-title":"Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina breast cancer study","volume":"29","author":"Williams","year":"2018","journal-title":"Cancer Causes & Control: CCC"},{"issue":"11","key":"2024042901110140900_bqae031-B49","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1055-9965.EPI-13-0298","article-title":"Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review","volume":"22","author":"Gierisch","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3 Suppl","key":"2024042901110140900_bqae031-B50","first-page":"1s","article-title":"Collaborative group on hormonal factors in breast cancer","volume":"54","author":"Breast cancer and hormonal contraceptives: further results","year":"1996","journal-title":"Contraception"},{"issue":"17","key":"2024042901110140900_bqae031-B51","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/jnci\/81.17.1313","article-title":"Prospective study of oral contraceptive use and risk of breast cancer in women","volume":"81","author":"Romieu","year":"1989","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2024042901110140900_bqae031-B52","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.breast.2012.08.005","article-title":"Association between common risk factors and molecular subtypes in breast cancer patients","volume":"22","author":"Turkoz","year":"2013","journal-title":"Breast"},{"issue":"2","key":"2024042901110140900_bqae031-B53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/0008-5472.CAN-09-3460","article-title":"Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study","volume":"70","author":"Ma","year":"2010","journal-title":"Cancer Res"},{"issue":"2","key":"2024042901110140900_bqae031-B54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1023006000760","article-title":"Breast cancers among very young premenopausal women (United States)","volume":"14","author":"Althuis","year":"2003","journal-title":"Cancer Causes Control"},{"issue":"2","key":"2024042901110140900_bqae031-B55","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10549-011-1616-x","article-title":"Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger","volume":"130","author":"Gaudet","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"2024042901110140900_bqae031-B56","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1158\/0008-5472.CAN-13-3400","article-title":"Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age","volume":"74","author":"Beaber","year":"2014","journal-title":"Cancer Res"},{"issue":"6","key":"2024042901110140900_bqae031-B57","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ijc.11307","article-title":"Oral contraceptive use and risk of breast cancer by histologic type","volume":"106","author":"Newcomer","year":"2003","journal-title":"Int J Cancer"},{"issue":"4","key":"2024042901110140900_bqae031-B58","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ijc.23163","article-title":"The association between oral contraceptive use and lobular and ductal breast cancer in young women","volume":"122","author":"Nyante","year":"2008","journal-title":"Int J Cancer"},{"issue":"4","key":"2024042901110140900_bqae031-B59","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ijc.11465","article-title":"Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65\u201379 years of age","volume":"107","author":"Li","year":"2003","journal-title":"International Journal of Cancer"},{"issue":"10","key":"2024042901110140900_bqae031-B60","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-10-0747","article-title":"Oral contraceptive use and breast cancer: a prospective study of young women","volume":"19","author":"Hunter","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"2024042901110140900_bqae031-B61","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/aogs.13817","article-title":"Levonorgestrel-releasing intrauterine system and breast cancer risk: a systematic review and meta-analysis","volume":"99","author":"Conz","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"2024042901110140900_bqae031-B62","doi-asserted-by":"crossref","first-page":"e1004188","DOI":"10.1371\/journal.pmed.1004188","article-title":"Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case-control study and meta-analysis","volume":"20","author":"Fitzpatrick","year":"2023","journal-title":"PLoS Med"},{"issue":"7","key":"2024042901110140900_bqae031-B63","doi-asserted-by":"crossref","first-page":"e14314","DOI":"10.15252\/emmm.202114314","article-title":"Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation","volume":"13","author":"Shamseddin","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"2","key":"2024042901110140900_bqae031-B64","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/0284186X.2015.1062538","article-title":"Levonorgestrel-releasing intrauterine system and the risk of breast cancer: a nationwide cohort study","volume":"55","author":"Soini","year":"2016","journal-title":"Acta Oncol"},{"issue":"9470","key":"2024042901110140900_bqae031-B65","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Endometrial cancer and hormone-replacement therapy in the million women study","volume":"365","author":"Beral","year":"2005","journal-title":"Lancet"},{"issue":"22","key":"2024042901110140900_bqae031-B66","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1001\/jama.281.22.2091","article-title":"Hormone replacement therapy and risk of breast cancer with a favorable HistologyResults of the Iowa Women's health study","volume":"281","author":"Gapstur","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"2024042901110140900_bqae031-B67","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","article-title":"Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk","volume":"283","author":"Schairer","year":"2000","journal-title":"Jama"},{"issue":"12","key":"2024042901110140900_bqae031-B68","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/jcp.51.12.935","article-title":"Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study","volume":"51","author":"O\u2019Connor","year":"1998","journal-title":"J Clin Pathol"},{"issue":"11","key":"2024042901110140900_bqae031-B69","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O","article-title":"Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women","volume":"88","author":"Li","year":"2000","journal-title":"Cancer"},{"issue":"12","key":"2024042901110140900_bqae031-B70","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/cncr.10984","article-title":"Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma","volume":"95","author":"Daling","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"2024042901110140900_bqae031-B71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/1055-9965.EPI-07-0558","article-title":"Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas","volume":"17","author":"Li","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"24","key":"2024042901110140900_bqae031-B72","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1001\/jama.289.24.3254","article-title":"Relationship between long durations and different regimens of hormone therapy and risk of breast cancer","volume":"289","author":"Li","year":"2003","journal-title":"Jama"},{"issue":"2","key":"2024042901110140900_bqae031-B73","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10549-014-2960-4","article-title":"Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55\u201374 years of age","volume":"145","author":"Li","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2024042901110140900_bqae031-B74","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/bcr1378","article-title":"Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study","volume":"8","author":"Rosenberg","year":"2006","journal-title":"Breast Cancer Res"},{"issue":"8","key":"2024042901110140900_bqae031-B75","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cam4.474","article-title":"Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort study","volume":"4","author":"Suhrke","year":"2015","journal-title":"Cancer Med"},{"issue":"4","key":"2024042901110140900_bqae031-B76","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ijc.23655","article-title":"Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy","volume":"123","author":"Flesch-Janys","year":"2008","journal-title":"Int J Cancer"},{"issue":"11","key":"2024042901110140900_bqae031-B77","doi-asserted-by":"crossref","first-page":"e78016","DOI":"10.1371\/journal.pone.0078016","article-title":"Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France","volume":"8","author":"Cordina-Duverger","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"2024042901110140900_bqae031-B78","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.289.11.1421","article-title":"Trends in incidence rates of invasive lobular and ductal breast carcinoma","volume":"289","author":"Li","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"2024042901110140900_bqae031-B79","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1097\/01.AOG.0000241091.86268.6e","article-title":"Breast cancer risk in postmenopausal women using estrogen-only therapy","volume":"108","author":"Lyytinen","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"7","key":"2024042901110140900_bqae031-B80","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.23786","article-title":"Reproductive and hormonal risk factors for postmenopausal luminal, HER-2\u2013overexpressing, and triple-negative breast cancer","volume":"113","author":"Phipps","year":"2008","journal-title":"Cancer"},{"issue":"15","key":"2024042901110140900_bqae031-B81","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"JAMA"},{"issue":"9","key":"2024042901110140900_bqae031-B82","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/annonc\/mdr613","article-title":"Reproductive and hormonal risk factors for luminal, HER2\u2013overexpressing, and triple-negative breast cancer in Japanese women","volume":"23","author":"Islam","year":"2012","journal-title":"Ann Oncol"},{"issue":"1","key":"2024042901110140900_bqae031-B83","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13058-016-0798-x","article-title":"Parity, hormones and breast cancer subtypes\u2014results from a large nested case-control study in a national screening program","volume":"19","author":"Ellingjord-Dale","year":"2017","journal-title":"Breast Cancer Res"},{"issue":"12","key":"2024042901110140900_bqae031-B84","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/aje\/kwx206","article-title":"Epidemiologic risk factors for in situ and invasive breast cancers among postmenopausal women in the national institutes of health-AARP diet and health study","volume":"186","author":"Mullooly","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"17","key":"2024042901110140900_bqae031-B85","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.3390\/cancers15174397","article-title":"DCIS and LCIS: are the risk factors for developing in situ breast cancer different?","volume":"15","author":"Timbres","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"9","key":"2024042901110140900_bqae031-B86","doi-asserted-by":"crossref","first-page":"bqaa109","DOI":"10.1210\/endocr\/bqaa109","article-title":"Differential regulation and targeting of estrogen receptor \u03b1 turnover in invasive lobular breast carcinoma","volume":"161","author":"Sreekumar","year":"2020","journal-title":"Endocrinology"},{"issue":"5","key":"2024042901110140900_bqae031-B87","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1158\/0008-5472.CAN-13-2779","article-title":"Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response","volume":"74","author":"Sikora","year":"2014","journal-title":"Cancer Res"},{"issue":"8","key":"2024042901110140900_bqae031-B88","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1158\/1541-7786.MCR-21-0025","article-title":"Mediator of DNA damage checkpoint 1 (MDC1) is a novel estrogen receptor coregulator in invasive lobular carcinoma of the breast","volume":"19","author":"Sottnik","year":"2021","journal-title":"Mol Cancer Res"},{"key":"2024042901110140900_bqae031-B89","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semcancer.2017.03.007","article-title":"Transcriptomic and genomic features of invasive lobular breast cancer","volume":"44","author":"Desmedt","year":"2017","journal-title":"Semin Cancer Biol"},{"issue":"20","key":"2024042901110140900_bqae031-B90","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1158\/0008-5472.CAN-21-3186","article-title":"A distinct chromatin state drives therapeutic resistance in invasive lobular breast cancer","volume":"82","author":"Nardone","year":"2022","journal-title":"Cancer Res"},{"issue":"5","key":"2024042901110140900_bqae031-B91","doi-asserted-by":"crossref","first-page":"641","DOI":"10.15252\/embj.201490434","article-title":"Progesterone and wnt4 control mammary stem cells via myoepithelial crosstalk","volume":"34","author":"Rajaram","year":"2015","journal-title":"EMBO J"},{"issue":"1","key":"2024042901110140900_bqae031-B92","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13058-016-0748-7","article-title":"WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines","volume":"18","author":"Sikora","year":"2016","journal-title":"Breast Cancer Res"},{"issue":"9","key":"2024042901110140900_bqae031-B93","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/bjc.1997.523","article-title":"E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis","volume":"76","author":"Vos","year":"1997","journal-title":"Br J Cancer"},{"issue":"17","key":"2024042901110140900_bqae031-B94","first-page":"5203","article-title":"Estrogen-mediated down-regulation of E-cadherin in breast cancer cells","volume":"63","author":"Oesterreich","year":"2003","journal-title":"Cancer Res"},{"issue":"18","key":"2024042901110140900_bqae031-B95","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1073\/pnas.0903033106","article-title":"ER\u03b1 as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells","volume":"106","author":"Cardamone","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2024042901110140900_bqae031-B96","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13058-015-0580-5","article-title":"Molecular drivers of lobular carcinoma in situ","volume":"17","author":"Logan","year":"2015","journal-title":"Breast Cancer Research: BCR"},{"issue":"10","key":"2024042901110140900_bqae031-B97","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41416-020-1023-3","article-title":"The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ","volume":"123","author":"Miligy","year":"2020","journal-title":"Br J Cancer"},{"issue":"33","key":"2024042901110140900_bqae031-B98","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","article-title":"Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk","volume":"33","author":"King","year":"2015","journal-title":"J Clin Oncol"},{"key":"2024042901110140900_bqae031-B99","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.breast.2021.07.020","article-title":"Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in The Netherlands: a population-based analysis","volume":"59","author":"van Maaren","year":"2021","journal-title":"Breast"},{"issue":"9","key":"2024042901110140900_bqae031-B100","doi-asserted-by":"crossref","first-page":"e2017124","DOI":"10.1001\/jamanetworkopen.2020.17124","article-title":"Association of a diagnosis of ductal carcinoma in situ with death from breast cancer","volume":"3","author":"Giannakeas","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"2024042901110140900_bqae031-B101","doi-asserted-by":"crossref","first-page":"e2342270","DOI":"10.1001\/jamanetworkopen.2023.42270","article-title":"Survival outcomes in premenopausal patients with invasive lobular carcinoma","volume":"6","author":"Yoon","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"2024042901110140900_bqae031-B102","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1210\/me.2015-1152","article-title":"Minireview: progesterone regulation of proliferation in the normal human breast and in breast cancer: a tale of two scenarios?","volume":"29","author":"Hilton","year":"2015","journal-title":"Mol Endocrinol"},{"issue":"1","key":"2024042901110140900_bqae031-B103","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-017-0462-7","article-title":"Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs","volume":"10","author":"Knutson","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"7299","key":"2024042901110140900_bqae031-B104","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature09027","article-title":"Control of mammary stem cell function by steroid hormone signalling","volume":"465","author":"Asselin-Labat","year":"2010","journal-title":"Nature"},{"issue":"7","key":"2024042901110140900_bqae031-B105","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1073\/pnas.0915148107","article-title":"Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland","volume":"107","author":"Beleut","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"182","key":"2024042901110140900_bqae031-B106","doi-asserted-by":"crossref","first-page":"182ra55","DOI":"10.1126\/scitranslmed.3005654","article-title":"Progesterone\/RANKL is a Major regulatory axis in the human breast","volume":"5","author":"Tanos","year":"2013","journal-title":"Sci Transl Med"},{"issue":"1","key":"2024042901110140900_bqae031-B107","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1038\/s41467-022-30898-0","article-title":"Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor","volume":"13","author":"Scabia","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"2024042901110140900_bqae031-B108","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1530\/ERC-11-0378","article-title":"Antiprogestins in breast cancer treatment: are we ready?","volume":"19","author":"Claudia","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"2024042901110140900_bqae031-B109","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1093\/annonc\/mdt216","article-title":"Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer","volume":"24","author":"Jonat","year":"2013","journal-title":"Ann Oncol"},{"issue":"8","key":"2024042901110140900_bqae031-B110","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1023\/A:1020239211145","article-title":"Obesity, body size, and risk of postmenopausal breast cancer: the Women's health initiative (United States)","volume":"13","author":"Morimoto","year":"2002","journal-title":"Cancer Causes Control"},{"issue":"5","key":"2024042901110140900_bqae031-B111","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10552-005-0001-7","article-title":"Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States)","volume":"17","author":"Li","year":"2006","journal-title":"Cancer Causes Control"},{"key":"2024042901110140900_bqae031-B112","doi-asserted-by":"crossref","first-page":"112988","DOI":"10.1016\/j.ejca.2023.112988","article-title":"Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer","volume":"191","author":"Van Baelen","year":"2023","journal-title":"Eur J Cancer"},{"issue":"9","key":"2024042901110140900_bqae031-B113","doi-asserted-by":"crossref","first-page":"djx001","DOI":"10.1093\/jnci\/djx001","article-title":"Mammographic density change with estrogen and progestin therapy and breast cancer risk","volume":"109","author":"Byrne","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"2024042901110140900_bqae031-B114","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"Jama"},{"issue":"24","key":"2024042901110140900_bqae031-B115","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1200\/JCO.2009.26.4770","article-title":"Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use","volume":"28","author":"Kerlikowske","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"2024042901110140900_bqae031-B116","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13058-021-01482-z","article-title":"Mammary collagen architecture and its association with mammographic density and lesion severity among women undergoing image-guided breast biopsy","volume":"23","author":"Bodelon","year":"2021","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2024042901110140900_bqae031-B117","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13058-015-0592-1","article-title":"High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium","volume":"17","author":"Huo","year":"2015","journal-title":"Breast Cancer Res"},{"key":"2024042901110140900_bqae031-B118","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.matbio.2021.10.006","article-title":"Mammary collagen is under reproductive control with implications for breast cancer","volume":"105","author":"Guo","year":"2022","journal-title":"Matrix Biol"},{"issue":"3","key":"2024042901110140900_bqae031-B119","doi-asserted-by":"crossref","first-page":"e13180","DOI":"10.15252\/emmm.202013180","article-title":"Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1","volume":"13","author":"Sflomos","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"6","key":"2024042901110140900_bqae031-B120","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1245\/s10434-019-08126-9","article-title":"Do body mass Index and breast density impact cancer risk among women with lobular carcinoma in situ?","volume":"27","author":"Minami","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"21","key":"2024042901110140900_bqae031-B121","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.3390\/cancers13215396","article-title":"Atlas of lobular breast cancer models: challenges and strategic directions","volume":"13","author":"Sflomos","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqae031\/57117160\/bqae031.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/165\/5\/bqae031\/57339831\/bqae031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/165\/5\/bqae031\/57339831\/bqae031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T01:11:51Z","timestamp":1714353111000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqae031\/7637246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":121,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3,29]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqae031","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,3,29]]},"article-number":"bqae031"}}